ATOS's logo.
Ticker Symbol: ATOS

Atossa Therapeutics Inc

$2.50 - 04-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001488039

Company Profile

atossa therapeutics, inc. develops and markets medical devices, laboratory tests, and therapeutics to address breast health conditions in the united states. the company's lead program is the development of endoxifen, an active metabolite of tamoxifen which is in phase ii studies to treat and prevent breast cancer. it is also developing intraductal microcatheter technology to target the delivery of therapies, including fulvestrant, immunotherapies, and chimeric antigen receptor t-cell therapies, directly to the site of breast cancer. the company was formerly known as atossa genetics inc. and changed its name to atossa therapeutics, inc. in january 2020. atossa therapeutics, inc. was founded in 2009 and is headquartered in seattle, washington.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: 107 Spring St
CEO: Steven Quay
Tags:
  • Health Technology
  • Medical Specialties
  • Manufacturing
  • Surgical and Medical Instrument Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.66
Change: - ( 0.00%)
Days Range: $0.65 - $0.67
Beta: 0.64
52wk. High: $1.39
52wk. Low: $0.50
Ytd. Change 24.88%
50 Day Moving Average: $0.74
200 Day Moving Average: $0.86
Shares Outstanding: 125785200

Valuation

Market Cap: 8.3B
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A